ClinicalTrials.gg
RecruitingNCT07489937Updated Apr 22, 2026

Supraspinatus Tendon Acute Effects After Two Exercise Exposures: a Crossover Randomized Trial.

An interventional study of Isotonic exercise program and Plyometric exercise program in Shoulder Pain and Healthy Adult, sponsored by University of Florida. Recruiting at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by University of Florida · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 146 studies in Shoulder Pain with a site in United States — 21 open to participants now, 28 under way, none of them phase 3. Shoulder Pain · United States.

Planned enrollment
91st of 122
24 · median 50
Started
2026
with 2 others
No phase
78 of 146
12 open now
Primary completion
2027-04
later than 16 of 27 live
Registered
144th of 146
by date

Among the 146 studies in Shoulder Pain with a site in United States, this one is the 91st largest by planned enrollment of the 122 interventional ones that give a count, is one of 3 that started in 2026, is one of 78 with no phase, reaches primary completion later than 16 of the 27 other live ones, and was the 144th registered.

Shoulder Pain

738 studies on the registry are indexed under Shoulder Pain; 168 are open to participants now.

Browse Shoulder Pain studies →

Open to participants now

21 of the 146 studies in Shoulder Pain with a site in United States are open now. Recruiting first, the newest first:

15 more — sign in →

All 21 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 90 Shoulder Pain studies recruiting now, 25 (28%) set no upper age limit and 55 (61%) stop at 75 or younger; 3 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 146 studies in Shoulder Pain with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to understand acute tendon changes after two exercise programs. We will invite individuals with and without shoulder pain to participate in this study. Every individual will participate in both exercise programs separated by up to 15 days. The researcher will evaluate the shoulder tendon using ultrasound before each exercise program and at 1 hour, 6 hours and 24 hours after each exercise program. The researcher will also evaluate self reported pain, pain sensitivity testing, and self reported questionnaires. We will compare the tendon changes after each exercise program, as well as between participants with and without shoulder pain.

03

Conditions studied

  • Shoulder Pain
  • Healthy Adult

Keywords

  • rotator cuff related shoulder pain
  • rotator cuff tendinopathy
  • shoulder pain
  • tendon thickness
  • exercise
  • subacromial pain
  • ultrasound
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

General inclusion criteria

  1. Between 18 and 45 years of age
  2. Able to perform physical activity with their shoulder (moderate arm exercise for 15 min, such as tennis or housework)

General exclusion criteria

  1. Shoulder fracture
  2. Frozen shoulder (>50% restriction in shoulder range of motion)
  3. Shoulder surgery
  4. Full rotator-cuff tears
  5. Bilateral shoulder pain
  6. Shoulder instability (history or positive apprehension test)
  7. injection in the last 6 weeks
  8. Neurological diseases
  9. Cardiological diseases
  10. Systemic diseases (rheumatic diseases, diseases)
  11. Uncontrolled diabetes
  12. Pregnancy

Group-specific inclusion criteria

  1. Shoulder pain group: report unilateral shoulder pain with an average shoulder pain score of≥ 3 in the last week.
  2. Control group: report no shoulder pain within 6 months.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Isotonic exercise then Plyometric exercise

    Behavioral: Isotonic exercise program · Behavioral: Plyometric exercise program

  • Experimental
    Plyometric exercise then Isotonic exercise

    Behavioral: Isotonic exercise program · Behavioral: Plyometric exercise program

Interventions

  • BehavioralIsotonic exercise program

    Participants will perform two isotonic exercises, prone shoulder external rotation and shoulder elevation. The exercises will be performed at a pace of 2-second for both concentric and eccentric phases. For each exercise, participants will perform two sets of 8 repetitions, followed by a third set performed until fatigue. Fatigue will be determined using the Repetition in Reserve Scale, which asks the participant to perform exercises until they reach a self-selected number corresponding to the number of repetitions left that a participant could still complete if needed. We will ask participants to continue the third set until they reach a Repetition in Reserve number of 1. The rest period will be 30 seconds between sets and 2 minutes between exercises. The exercise load will be selected after manual maximal isometric strength testing using a handheld dynamometer. A 40% of the strength testing will be used for exercises in both groups following strength guidelines.

  • BehavioralPlyometric exercise program

    Participants will perform two isotonic exercises, prone shoulder external rotation and shoulder elevation. The exercises will be performed at a pace of 1-second for the eccentric phases followed by an explosive concentric phase. For each exercise, participants will perform two sets of 8 repetitions, followed by a third set performed until fatigue. Fatigue will be determined using the Repetition in Reserve Scale, which asks the participant to perform exercises until they reach a self-selected number corresponding to the number of repetitions left that a participant could still complete if needed. Participants will complete the third set until they reach a Repetition in Reserve number of 1. The rest period will be 30 seconds between sets and 2 minutes between exercises. The exercise load will be selected after manual maximal isometric strength testing using a handheld dynamometer. A 40% of the strength testing will be used for exercises in both groups following strength guidelines.

06

What researchers measure

Primary outcomes

  1. Supraspinatus tendon thickness

    The investigators will use ultrasound to take pictures of the supraspinatus tendons. Established ultrasound procedures will be used to measure supraspinatus tendon thickness.

    Time frame: From enrollment to 1 hour, 6 hours, and 24 hours after each exercise program.

Secondary outcomes

  1. Pain sensitivity testing

    The investigators will apply pressure at a constant rate using a computerized pressure algometer with a 1 cm diameter rubber tip at the shoulder and the lower limb.

    Time frame: From enrollment to 1 hour, 6 hours, and 24 hours after each exercise program.

  2. Self-reported pain

    We will use an 11-point numeric pain rating scale to measure the shoulder pain perceived by the participant.

    Time frame: From enrollment to 1, 6, and 24 hours after each exercise program.

Other outcomes

  1. Rate of perceived exertion

    We will use a 11-point scale, 0 being no effort and 10 being the maximal effort, to understand the effort perceived after each exercise program.

    Time frame: Immediately after each exercise program.

  2. Pennsylvania Shoulder Score (PENN)

    The PENN is a valid and reliable self-reported questionnaire for patients with shoulder pain.

    Time frame: At baseline before each exercise program.

  3. Optimal Screening for Prediction of Referral and Outcome (OSPRO)

    The OSPRO is a concise, multidimensional 10-item yellow flag assessment tool that estimates 11 total questionnaire scores indicating elevated vulnerability and decreased resilience.

    Time frame: At baseline before the first exercise program.

  4. Global rating of change (GROC)

    The GROC is a rating scale that quantifies participants' improvement or deterioration of symptoms over time. Changes will be measured using a 15-points Likert scale (-7, a very great deal worse to 7, a very great deal better, with 0 indicating no changes).

    Time frame: At the second baseline before the second exercise program at 1 week.

  5. Tegner Activity Scale

    Is a valid and reliable tool that evaluates work and sport participation. It addresses both function and activity level, and it will provide information about the physical general activity of the individual.

    Time frame: At baseline before the first exercise program.

  6. Rate of perceived fatigue

    We will use a 11-point scale, 0 being no fatigue and 10 being the maximal fatigue, to understand the fatigue perceived after each exercise program.

    Time frame: Immediately after each exercise program

  7. Self-reported pain related to the exercise

    We will use an 11-point numeric pain rating scale to measure the shoulder pain perceived by the participant.

    Time frame: Before and immediately after each exercise program

  8. Muscle soreness

    We will use an 11-point numeric rating scale to measure the muscle soreness perceived by the participant after the exercise.

    Time frame: Before and immediately, 1, 6 and 24 hours after each exercise program

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan

Time frame: Study protocol \& statistical analysis plan: A manuscript describing the study protocol and statistical analysis plan will be submitted for publication before the end of the recruitment for the study.

Access criteria: Study protocol and statistical analysis plan: The manuscript will be published as open access.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Apr 2027, 11 months after the start.

Of 351 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 11 months is close to that.

Counting every sponsor, half of 356 studies reached it within 11 months; a quarter within 4 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2026
First posted
Mar 24, 2026
StartActual
Apr 20, 2026
Primary completionEst.
Apr 1, 2027
CompletionEst.
Apr 1, 2027
Last update
Apr 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07489937
Responsible party
Sponsor
First posted
Mar 24, 2026
Start date
Apr 20, 2026
Primary completion
Apr 1, 2027 (estimated)
Completion
Apr 1, 2027 (estimated)
Last update
Apr 22, 2026

Study contacts

Ignacio A Raguzzi, PT
Contact
iraguzzi@ufl.edu
352-665-4947

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion